DelveInsight expands market analysis services for siRNA therapeutics
Research and consulting firm DelveInsight has updated its market intelligence and competitive benchmarking services focused on small interfering RNA (siRNA) development.
DelveInsight has expanded its research and advisory portfolio dedicated to small interfering RNA (siRNA) therapeutics. The firm provides data-driven insights into market size, competitive landscapes, and regulatory hurdles, aimed at pharmaceutical companies navigating the RNA-based therapy sector.
The service expansion includes tools for pipeline assessment, patient journey mapping, and partner identification. As siRNA technology continues to attract investment in areas such as rare diseases and chronic conditions, DelveInsight aims to provide the necessary market intelligence for asset prioritization and portfolio management.
By focusing on therapeutic area analytics, the company supports business development activities ranging from mergers and acquisitions to market entry strategies. This move reflects the growing complexity of the global RNA therapeutics market and the need for specialized research support.